Completed Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium NCT00896454 Conditions Blood Protein Disorders, Breast Cancer, Breast Diseases, +77 more Locations Research Site — Encinitas, California, United States Research Site — New Haven, Connecticut, United States Research Site — Salisbury, Maryland, United States Research Site — Dearborn, Michigan, United States View all 24 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study NCT00580788 Conditions Bone Diseases, Bone Diseases, Metabolic, Endocrine System Diseases, +9 more Locations University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States View Trial Details
Completed Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases NCT00060138 Conditions Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more Locations Ireland Cancer Center — Cleveland, Ohio, United States View Trial Details
Completed Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone NCT00003884 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +20 more Locations SORRA Research Center — Birmingham, Alabama, United States Brookwood ACCC — Birmingham, Alabama, United States University of Alabama Comprehensive Cancer Center — Birmingham, Alabama, United States Highlands Oncology Group — Springdale, Arkansas, United States View all 55 locations View more locations Show fewer locations Loading locations... View Trial Details